Medplus Health Serv Ltd

NSE: MEDPLUS · Retailing · sector

₹608.15NSE close 2026-10-26

Key numbers

Market cap₹7,306 cr

Price₹608.15

52w high / low₹1,022 / ₹591

P/E34.7xSector median 42.9x

P/B3.7xSector median 3.8x

Book value₹164.4

Dividend yield–

ROE11.3%Sector median 9.3%

ROCE19.8%Sector median 16.0%

OPM8.4%Sector median 6.4%

Debt / equity0.00xSector median 0.17x

EV/EBITDA11.2xSector median 16.6x

Interest cover3.1x

Current ratio3.00x

Sales growth 3y+14.8%Sector median +14.8%

Profit growth 3y+64.0%Sector median +64.0%

PEG0.54x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 2 companies in Retailing (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹462 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 3.1x in the last 12 months.
74.02% of the promoters' shares are pledged (29.8% of all shares).
Operating cash flow was below net profit in 0 of the last 5 years.
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 36% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹608.15 on 2026-10-26: -40.5% from the 52-week high, +2.8% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹949.25 · low ₹608.15

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1,576	1,561	1,510	1,543	1,679	1,806	1,864	1,880
EBITDA	124	133	136	131	149	159	169	133
OPM %	7.9%	8.5%	9.0%	8.5%	8.9%	8.8%	9.1%	7.1%
Other income	12	13	16	15	17	18	21	20
Net profit	39	46	51	42	56	58	64	33
EPS (₹)	3.24	3.84	4.32	3.54	4.63	4.82	5.33	2.76
Revenue YoY					+6.5%	+15.7%	+23.5%	+21.8%
Profit YoY					+43.3%	+26.0%	+24.6%	-21.7%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	3,779	4,558	5,625	6,136	6,892	7,229
EBITDA	272	266	354	487	607	610
Net profit	96	50	65	150	220	210
EPS (₹)	8.55	4.17	5.48	12.57	18.33	17.54
Revenue growth		+20.6%	+23.4%	+9.1%	+12.3%	+16.8%
Profit growth		-48.1%	+31.6%	+129.6%	+46.1%	+18.0%
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+14.8%	–	+16.8%
Net profit	+64.0%	–	+18.0%
EPS	+63.8%	–	–
Share price	–	-6.5% (2y)	-21.4%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	1,491	1,578	1,741	1,975
Borrowings	–	0	0	0	0
Cash & equivalents	–	284	142	367	462
Total assets	–	2,797	3,005	3,360	3,933
Fixed assets	–	288	319	291	318
Capital work in progress	–	24	5	13	32
Investments	–	0	0	0	0
Receivables	–	9	18	13	27
Inventory	–	1,144	1,340	1,345	1,382
Payables	–	260	253	299	307

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	170	90	144	540	496
Cash from investing	-703	429	-83	-318	-128
Cash from financing	440	-170	-198	-228	-256
Capex	118	169	84	59	123
Free cash flow	52	-79	59	481	373

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	3.3%	4.1%	8.6%	11.1%
ROCE %	–	8.7%	10.8%	16.4%	20.0%
Debtor days	–	1	1	1	1
Inventory days	–	117	111	106	99
Payable days	–	27	21	24	22
Cash conversion cycle (days)	–	91	91	83	78
Working capital days	–	80	68	75	73

Shareholding

Holder	% (2026-09-30)
Promoters	40.19%
FIIs	12.58%
DIIs	31.89%
of which Mutual funds	27.39%
of which Insurance	1.19%
Public (non-institutions)	15.29%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	40.39%	40.34%	40.32%	40.29%	40.29%	40.22%	40.19%	40.19%

Promoter group	%
Lone Furrow Investments Private Limited	14.38%
Agilemed Investments Private Limited	13.03%
Madhukar Reddy Gangadi	12.78%
Rajita Reddy Gangadi	0.01%
Renuka Gangadi	0.00%
Gangadi Veera Reddy	0.00%
Gangadi Sugunamma	0.00%
Varin Nair	0.00%
G Narsimha Reddy	0.00%
Inder Mohan Aggarwal	0.00%
Ranjana Aggarwal	0.00%
Neeraj Aggarwal	0.00%
Gangadi Investments Private Limited	0.00%
Hinshitsu Manufacturing Private Limited	0.00%
Madhukar Gangadi Ventures Private Limited	0.00%

Public holders above 1%	%
ICICI Prudential Healthcare Fund	7.46%
Nippon Life India Trustee Ltd-a/c Nippon India PHA	7.32%
Franklin India Flexi CAP Fund	3.90%
SBI Elss TAX Saver Fund	3.39%
Kotak Small CAP Fund	3.31%
Fidelity Funds - India Focus Fund	1.68%
Pravesa Holding Private Limited	1.51%
Bajaj Life Insurance Limited	1.04%

77,714 shareholders. Pledged: 74.02% of promoter shares.

Peers in Retailing

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
MEDPLUS	₹7,306 cr	34.7x	3.7x	11.3%	19.8%	8.4%	+14.8%	–
ENTERO	₹6,420 cr	51.2x	3.8x	7.3%	12.2%	4.3%	–	–

All 2 companies in Retailing →

Business segments (FY26)

Segment	Revenue	Share	EBIT	Margin
Retail	₹6,760 cr	98.1%	₹239 cr	3.5%
Diagnostic services	₹131 cr	1.9%	₹2 cr	1.3%
Others	₹1 cr	0.0%	₹1 cr	48.9%

Documents

Links go to the original files on the exchange website.

About the company

Hospital and Medical Care: Pharmaceutical products, Medical and orthopedic goods
Hospital and Medical Care: Diagnostic-imaging services


Sector	Consumer Discretionary
Industry	Retailing
Sub-industry	Pharmacy Retail
Symbol	MEDPLUS
BSE code	543427
ISIN	INE804L01022
Face value	₹2.0
Incorporated	2006-11-30
Website	www.medplusindia.com
Plants (India / abroad)	5 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.